Prihlásiť sa Zaregistrujte sa zadarmo

Príjmy spoločnosti Genocea Biosciences Inc

Aká je hodnota metriky Príjmy spoločnosti Genocea Biosciences Inc?

Hodnota metriky Príjmy spoločnosti Genocea Biosciences Inc je -$37.19

Aká je definícia metriky Príjmy?

Výsledok príjmov pre kmeňových akcionárov (Income) sa rovná celkovému príjmu mínus vyplatené prioritné dividendy.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Príjmy spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Genocea Biosciences Inc

Čomu sa venuje spoločnosť Genocea Biosciences Inc?

Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.

Firmy s metrikou príjmy podobnou spoločnosti Genocea Biosciences Inc